Markets & Finance

Cutting Forecast for El Paso


Company: ATMI Inc (ATMI)

Year ending: Dec-03

Prior estimate: 0.12

New estimate: 0.14

Rationale: Company guidance, improving semiconductor unit

Company: AVX Corp (AVX)

Year ending: Mar-04

Prior estimate: 0.25

New estimate: 0.10

Rationale: Company guidance

Company: Broadcom Corp (BRCM)

Year ending: Dec-03

Prior estimate: 0.22

New estimate: 0.20

Rationale: Low visibility, staff cuts, CEO quits

Company: Centillium (CTLM)

Year ending: Dec-03

Prior estimate: -0.52

New estimate: -0.44

Rationale: Company sharply cutting costs

Company: Computer Sciences (CSC)

Year ending: Mar-04

Prior estimate: 2.91

New estimate: 3.62

Rationale: Acquisition of DynCorp

Company: Crompton Corp (CK)

Year ending: Dec-03

Prior estimate: 0.75

New estimate: 0.50

Rationale: Company guidance

Company: Dow Chemical (DOW)

Year ending: Dec-03

Prior estimate: 1.50

New estimate: 0.90

Rationale: Much higher feedstock costs

Company: Eastman Chemical (EMN)

Year ending: Dec-03

Prior estimate: 2.25

New estimate: 2.00

Rationale: Higher raw material costs

Company: El Paso Corp (EP)

Year ending: Dec-03

Prior estimate: 1.50

New estimate: 0.75

Rationale: Major writedown, exiting LNG business

Company: Exxon Mobil (XOM)

Year ending: Dec-03

Prior estimate: 2.03

New estimate: 2.09

Rationale: Fourth-quarter EPS, conference call

Company: Inco Ltd (N)

Year ending: Dec-03

Prior estimate: 1.60

New estimate: 1.25

Rationale: Rising production, pension costs

Company: MKS Instruments (MKSI)

Year ending: Dec-03

Prior estimate: -0.05

New estimate: 0.09

Rationale: Sales appear to be stabilizing

Company: Myriad Genetics (MYGN)

Year ending: Jun-03

Prior estimate: -0.89

New estimate: -1.03

Rationale: Higher costs

Company: Patterson-UTI (PTEN)

Year ending: Dec-03

Prior estimate: 0.98

New estimate: 0.54

Rationale: Fourth-quarter EPS, conference call

Company: Post Properties (PPS)

Year ending: Dec-03

Prior estimate: 0.79

New estimate: 0.21

Rationale: Declining occupancy, rents

Company: Vertex Pharmaceuticals (VRTX)

Year ending: Dec-03

Prior estimate: -1.29

New estimate: -1.77

Rationale: Higher than expected costs

Feb. 4

Company: Argosy Gaming (AGY)

Year ending: Dec-03

Prior estimate: 2.80

New estimate: 2.40

Rationale: Higher tax; competitor expansions

Company: ASML Holding (ASML)

Year ending: Dec-03

Prior estimate: 0.13

New estimate: 0.05

Rationale: Continued soft spending on semiconductor equipment

Company: Fleming Cos (FLM)

Year ending: Dec-03

Prior estimate: 1.20

New estimate: 0.75

Rationale: Struggling distribution business

Company: Hologic Inc (HOLX)

Year ending: Sep-03

Prior estimate: 0.55

New estimate: 0.20

Rationale: Slow sales, see SG&A spike

Company: ICN Pharmaceuticals (ICN)

Year ending: Dec-03

Prior estimate: 0.85

New estimate: 0.70

Rationale: Significant rival price cut

Company: Kulicke & Soffa (KLIC)

Year ending: Sep-03

Prior estimate: -0.51

New estimate: -0.57

Rationale: Company guidance

Company: Level 3 Communications (LVLT)

Year ending: Dec-03

Prior estimate: -2.21

New estimate: -2.62

Rationale: Demand not improving as expected

Company: Louisiana-Pacific (LPX)

Year ending: Dec-03

Prior estimate: 0.30

New estimate: -0.10

Rationale: Weaker wood, lumber prices

Company: PACCAR (PCAR)

Year ending: Dec-03

Prior estimate: 2.68

New estimate: 3.31

Rationale: Top line growth; margin assumptions

Feb. 3

Company: Janus Capital (JNS)

Year ending: Dec-03

Prior estimate: 0.91

New estimate: 0.71

Rationale: Expected drop in average assets

Company: Photon Dynamics (PHTN)

Year ending: Sep-03

Prior estimate: 0.21

New estimate: -0.86

Rationale: Lower guidance

Company: Smith International (SII)

Year ending: Dec-03

Prior estimate: 1.48

New estimate: 1.23

Rationale: Based on fourth-quarter EPS, conference call

Company: VISX Inc (EYE)

Year ending: Dec-03

Prior estimate: 0.46

New estimate: 0.39

Rationale: Economy improving slower than expected

Feb. 1

Company: Amerada Hess (AHC)

Year ending: Dec-03

Prior estimate: 5.89

New estimate: 4.81

Rationale: Concerns over BOE production cuts


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus